Add to ORKGThe prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-stage non-small-cell lung cancer (NSCLC) varies by population examined and detection method used. The Lungscape ALK project was designed to address the prevalence and prognostic impact of ALK positivity in resected lung adenocarcinoma in a primarily European population.status: publishe
Abstract Background Rearrangements in the anaplastic lymphoma kinase (ALK) gene define a molecular s...
Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
IntroductionThe EML4–anaplastic lymphoma kinase (ALK) translocation is a recognized oncogenic driver...
Purpose The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-sta...
PURPOSE: The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-st...
PURPOSE: The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-st...
Real-world clinical outcomes of anaplastic lymphoma kinase positive (ALK+) non-small cell lung cance...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NSCLC ranges fro...
Abstract Purpose To analyze the characteristics and prognostic values of Anaplastic Lymphoma Kinase ...
To examine the prevalence of anaplastic lymphoma kinase (ALK) fusion gene in Chinese patients with n...
Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
BACKGROUND: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
The incidence of ALK gene rearrangement in non-small cell lung cancer (NSCLC) was about 3% to 5%. AL...
Abstract Background Rearrangements in the anaplastic lymphoma kinase (ALK) gene define a molecular s...
Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
IntroductionThe EML4–anaplastic lymphoma kinase (ALK) translocation is a recognized oncogenic driver...
Purpose The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-sta...
PURPOSE: The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-st...
PURPOSE: The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-st...
Real-world clinical outcomes of anaplastic lymphoma kinase positive (ALK+) non-small cell lung cance...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NSCLC ranges fro...
Abstract Purpose To analyze the characteristics and prognostic values of Anaplastic Lymphoma Kinase ...
To examine the prevalence of anaplastic lymphoma kinase (ALK) fusion gene in Chinese patients with n...
Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
BACKGROUND: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
The incidence of ALK gene rearrangement in non-small cell lung cancer (NSCLC) was about 3% to 5%. AL...
Abstract Background Rearrangements in the anaplastic lymphoma kinase (ALK) gene define a molecular s...
Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a sub...
IntroductionThe EML4–anaplastic lymphoma kinase (ALK) translocation is a recognized oncogenic driver...